Search - tctmd.com

Displaying 1 - 20 of 111

Sort: Relevancy | Date

Presentation TCT 2025

How Data from the AHA and C3TN Registries of Cardiogenic Shock can Improve Care of Patients with Cardiogenic Shock

Presenter: David A. Morrow

October 28, 2025

Presentation TCT 2025

TCT 259: Utilization of Mechanical Circulatory Support and In-Hospital Outcomes in Patients with Cardiogenic Shock and Right Ventricular Failure: A Study from the AHA Cardiogenic Shock Registry

Presenter: Wissam Harmouch

October 27, 2025

Presentation TCT 2025

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

Presenter: Linda D. Gillam

October 26, 2025

Presentation TCT 2024

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Presenter: Brian Lindman

October 30, 2024

Presentation TCT 2024

Highlights From the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (What to Know)

Presenter: Brahmajee Nallamothu

October 28, 2024

Presentation TCT 2024

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization

Presenter: Jacqueline Tamis-Holland

October 28, 2024

Presentation TCT 2024

The AHA Cardiogenic Shock Registry: Goals and Status Update

Presenter: Mariell Jessup

October 28, 2024

Presentation TCT 2023

Where Do Antithrombotics Fit In?

Presenter: Marc Bonaca

October 26, 2023

Presentation TCT 2023

Beyond LDL

Presenter: Pieter Smits

October 26, 2023

Presentation TCT 2023

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

Presenter: Eldrin Lewis

October 26, 2023

Presentation TCT 2023

Lipoprotein(a): Why Measure and What to Do?

Presenter: Sotirios Tsimikas

October 26, 2023

Presentation TCT 2023

Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid

Presenter: Karol Watson

October 26, 2023

Presentation TCT 2023

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Presenter: Amit Khera

October 26, 2023

Presentation TCT 2023

Secondary Prevention Case: Complex PCI in Stable Patient (No Prior MI)

Presenter: Lauren Ranard

October 26, 2023

Presentation TCT 2023

Case 3: High Risk Intermediate PE With Iliocaval DVT

Presenter: Sonal Pruthi

October 26, 2023

Presentation TCT 2023

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Presenter: Sameer Khandhar

October 26, 2023

Presentation TCT 2023

Case 1: Massive PE With Shock

Presenter: Peter Monteleone

October 26, 2023

Presentation TCT 2023

Outside the Box Surgical Options for MAC

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

LVOT Management

Presenter: Brian Whisenant

October 25, 2023

Advertisement

How Data from the AHA and C3TN Registries of Cardiogenic Shock can Improve Care of Patients with Cardiogenic Shock

TCT 259: Utilization of Mechanical Circulatory Support and In-Hospital Outcomes in Patients with Cardiogenic Shock and Right Ventricular Failure: A Study from the AHA Cardiogenic Shock Registry

From Detection to Early Intervention: Optimizing Active Surveillance with AHA’s Target: Aortic Stenosis

The Rise of AHA Target: Aortic Stenosis – Applying Quality Improvement Upstream of the Procedure (in partnership with the American Heart Association)

Impact of Delays in Diagnosis and Treatment: Join the AHA TARGET AS Program!

Highlights From the 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (What to Know)

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization

The AHA Cardiogenic Shock Registry: Goals and Status Update

Where Do Antithrombotics Fit In?

Beyond LDL

Expanding Your Lane and Not Your Waist: Cardiologists and GLP1-RA/SGLT2i

Lipoprotein(a): Why Measure and What to Do?

Applying New LDL-C Lowering Agents: Update on PCSK9mab, Inclisaran, and Bempedoic Acid

Identifying the Highest Risk Secondary Prevention Patient Post PCI: What to Look For?

Secondary Prevention Case: Complex PCI in Stable Patient (No Prior MI)

Case 3: High Risk Intermediate PE With Iliocaval DVT

Case 2: Neurosurgical Patient With High Risk Intermediate PE

Case 1: Massive PE With Shock

Outside the Box Surgical Options for MAC

LVOT Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content